Open | - |
Close | - |
Volume / Avg. | 0 / 809.432K |
Day Range | - - - |
52 Wk Range | 3.000 - 17.791 |
Market Cap | $619.535M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 14.81% |
Days to Cover | 8.14 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Olema Pharmaceuticals (NASDAQ: OLMA) through any online brokerage.
Other companies in Olema Pharmaceuticals’s space includes: Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT), Larimar Therapeutics (NASDAQ:LRMR), Fate Therapeutics (NASDAQ:FATE) and AnaptysBio (NASDAQ:ANAB).
The latest price target for Olema Pharmaceuticals (NASDAQ: OLMA) was reported by Oppenheimer on Tuesday, March 12, 2024. The analyst firm set a price target for 21.00 expecting OLMA to rise to within 12 months (a possible 89.53% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Olema Pharmaceuticals (NASDAQ: OLMA) is $11.08 last updated March 18, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Olema Pharmaceuticals.
Olema Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Olema Pharmaceuticals.
Olema Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.